Canaccord Adams Maintains a 'Speculative Buy'on AEterna Zentaris (AEZS); Positive FDA Data From Partner Keryx Pharmaceuticals (KERX) Apr 5, 2010 03:18PM
Canaccord Adams Downgrades AEterna Zentaris (AEZS) to Speculative Buy; Negative Phase III Study Results Aug 18, 2009 11:01AM